Ingevity reported Q4 2025 results with sales of $373M, exceeding guidance. Adjusted EBITDA was $86M. The Performance Chemicals segment saw strong demand in pavement technologies and industrial specialties, while Engineered Polymers faced headwinds. The company is focusing on debt reduction.
Comments